Niva Bupa Deviation Statement for Quarter Ended September 2025

Niva Bupa Health Insurance Company Limited has released a statement regarding the deviation or variation in the utilization of funds raised through its Initial Public Offering (IPO). The statement, for the quarter ended September 30, 2025, confirms that there were no deviations in the use of funds. The original plan was to augment the capital base with INR 800.00 crores, and the funds were utilized accordingly, maintaining solvency levels.

Funds Utilization Report

Niva Bupa Health Insurance Company Limited confirms no deviation or variation in the utilization of funds raised through its IPO, as per the statement released on November 03, 2025, for the quarter ending September 30, 2025.

Details of Funds Allocation

The original plan was to utilize INR 800.00 crores to augment the capital base, aimed at maintaining and strengthening solvency levels. The full amount of INR 800.00 crores has been utilized for this purpose. Therefore, there are no deviations to report for Q2 (July-September) of FY26.

Source: BSE

Previous Article

Kirloskar Brothers Unaudited Financial Results for Q2 & Half-Year Ended September 30, 2025

Next Article

Star Health H1 FY2026 PAT Up 21% to ₹518 Crore, Retail Health Market Share at 32%

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *